NSPR InspireMD, Inc.

Nasdaq inspiremd.com


$ 1.86 $ 0.02 (1.12 %)    

Friday, 21-Nov-2025 11:40:00 EST
QQQ $ 590.97 $ 3.60 (0.61 %)
DIA $ 463.91 $ 4.44 (0.97 %)
SPY $ 660.04 $ 5.02 (0.77 %)
TLT $ 89.33 $ -0.33 (-0.37 %)
GLD $ 376.55 $ 2.56 (0.68 %)
$ 1.7
$ 1.78
$ 1.81 x 100
$ 1.95 x 600
$ 1.80 - $ 1.94
$ 1.59 - $ 3.80
86,404
na
72.03M
$ 0.77
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-04-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 03-12-2025 12-31-2024 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-05-2024 06-30-2024 10-Q
7 05-13-2024 03-31-2024 10-Q
8 03-05-2024 12-31-2023 10-K
9 11-06-2023 09-30-2023 10-Q
10 08-07-2023 06-30-2023 10-Q
11 05-15-2023 03-31-2023 10-Q
12 03-30-2023 12-31-2022 10-K
13 11-07-2022 09-30-2022 10-Q
14 08-08-2022 06-30-2022 10-Q
15 05-09-2022 03-31-2022 10-Q
16 03-07-2022 12-31-2021 10-K
17 11-08-2021 09-30-2021 10-Q
18 08-09-2021 06-30-2021 10-Q
19 05-10-2021 03-31-2021 10-Q
20 03-08-2021 12-31-2020 10-K
21 11-09-2020 09-30-2020 10-Q
22 08-05-2020 06-30-2020 10-Q
23 05-11-2020 03-31-2020 10-Q
24 03-10-2020 12-31-2019 10-K
25 11-12-2019 09-30-2019 10-Q
26 08-05-2019 06-30-2019 10-Q
27 05-13-2019 03-31-2019 10-Q
28 02-19-2019 12-31-2018 10-K
29 11-06-2018 09-30-2018 10-Q
30 08-06-2018 06-30-2018 10-Q
31 05-07-2018 03-31-2018 10-Q
32 02-13-2018 12-31-2017 10-K
33 11-07-2017 09-30-2017 10-Q
34 08-08-2017 06-30-2017 10-Q
35 05-09-2017 03-31-2017 10-Q
36 02-16-2017 12-31-2016 10-K
37 11-14-2016 09-30-2016 10-Q
38 08-09-2016 06-30-2016 10-Q
39 05-10-2016 03-31-2016 10-Q
40 03-28-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 clinical-results-of-double-layer-micronet-stents-in-complex-anatomy--science-direct

https://www.sciencedirect.com/science/article/abs/pii/S0890509625004200

 inspiremd-receives-fda-premarket-application-approval-for-cguard-prime-carotid-stent-system

InspireMD, Inc. (the "Company") (NASDAQ:NSPR), developer of the CGuard Prime Carotid Stent System for the prevention of...

 piper-sandler-maintains-overweight-on-inspiremd-lowers-price-target-to-4

Piper Sandler analyst Adam Maeder maintains InspireMD (NASDAQ:NSPR) with a Overweight and lowers the price target from $4.5 ...

 inspiremd-q1-eps-022-misses-020-estimate-sales-153m-beat-145m-estimate

InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.20) b...

 inspiremd-q4-2024-gaap-eps-019-beats-020-estimate-sales-195m-beat-182m-estimate

InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION